| 000 | 01351 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515093550.0 | ||
| 264 | 0 | _c20080117 | |
| 008 | 200801s 0 0 eng d | ||
| 022 | _a0886-022X | ||
| 024 | 7 |
_a10.1080/08860220701540326 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPari, Leelavinothan | |
| 245 | 0 | 0 |
_aAntihyperlipidemic effect of curcumin and tetrahydrocurcumin in experimental type 2 diabetic rats. _h[electronic resource] |
| 260 |
_bRenal failure _c2007 |
||
| 300 |
_a881-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Glucose _xanalysis |
| 650 | 0 | 4 |
_aCholesterol, HDL _xblood |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 |
_aCurcumin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xmetabolism |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xmetabolism |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl CoA Reductases _xmetabolism |
| 650 | 0 | 4 |
_aHypolipidemic Agents _xpharmacology |
| 650 | 0 | 4 |
_aLipid Metabolism _xdrug effects |
| 650 | 0 | 4 |
_aLiver _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aStreptozocin |
| 700 | 1 | _aMurugan, Pidaran | |
| 773 | 0 |
_tRenal failure _gvol. 29 _gno. 7 _gp. 881-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/08860220701540326 _zAvailable from publisher's website |
| 999 |
_c17511879 _d17511879 |
||